Literature DB >> 24619655

High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.

G Sesti1, F Andreozzi, T V Fiorentino, G C Mannino, A Sciacqua, M A Marini, F Perticone.   

Abstract

Irisin, a novel myokine, was proposed to be able to regulate glucose homeostasis and obesity in mice. Whether irisin levels are associated with cardio-metabolic variables, insulin sensitivity, and vascular atherosclerosis in humans remain unsettled. To determine the associations between circulating irisin levels, cardio-metabolic variables, insulin sensitivity, and common carotid intima-media thickness (IMT), an indicator of vascular atherosclerosis, a cross-sectional evaluation of circulating irisin levels and cardio-metabolic variables in 192 White adults was conducted. Insulin sensitivity and insulin clearance were assessed by euglycemic-hyperinsulinemic clamp. Common carotid IMT was measured by ultrasound. After adjusting for age and gender, irisin levels were positively correlated with body fat mass (r = 0.12, P < 0.05), fasting (r = 0.17, P < 0.01), 2 h post-load insulin (r = 0.15, P < 0.02) levels, and IMT (r = 0.29, P < 0.0001) and were negatively correlated with insulin-stimulated glucose disposal (r = -0.18, P = 0.007), Matsuda index (r = -0.13, P < 0.04), disposition index (r = -0.278, P < 0.0001), and insulin clearance (r = -0.26, P < 0.0001). After adjusting for age, gender, and BMI, individuals in the highest tertile of irisin levels exhibited higher body fat mass (P < 0.01), fasting (P < 0.05), 2 h post-load (P < 0.01) insulin levels, carotid IMT (P < 0.001), lower insulin-stimulated glucose disposal (P < 0.001), Matsuda index (P < 0.01), disposition index (P < 0.01), and insulin clearance (P < 0.001) as compared with subjects in the lowest tertile of circulating irisin levels. Irisin is inversely associated with insulin sensitivity and positively associated with carotid IMT in humans, suggesting either increased release by adipose/muscle tissue in response to deterioration of insulin sensitivity or a compensatory increase in irisin to overcome an underlying irisin resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619655     DOI: 10.1007/s00592-014-0576-0

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  51 in total

Review 1.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

2.  Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study.

Authors:  Petter Bjornstad; David M Maahs; Christopher J Rivard; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon
Journal:  Acta Diabetol       Date:  2014-06-15       Impact factor: 4.280

3.  Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid.

Authors:  A E Huerta; P L Prieto-Hontoria; M Fernández-Galilea; N Sáinz; M Cuervo; J A Martínez; M J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2015-03-28       Impact factor: 4.158

4.  Central and peripheral irisin differentially regulate blood pressure.

Authors:  Weizhen Zhang; Lin Chang; Chao Zhang; Ruthann Zhang; Ziru Li; Biaoxin Chai; Jiyao Li; Eugene Chen; Michael Mulholland
Journal:  Cardiovasc Drugs Ther       Date:  2015-04       Impact factor: 3.727

Review 5.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

Review 6.  Chronic Exercise Training and Circulating Irisin in Adults: A Meta-Analysis.

Authors:  Shanhu Qiu; Xue Cai; Zilin Sun; Uwe Schumann; Martina Zügel; Jürgen Michael Steinacker
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

7.  Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?

Authors:  Beatriz García-Fontana; Rebeca Reyes-García; Sonia Morales-Santana; Verónica Ávila-Rubio; Araceli Muñoz-Garach; Pedro Rozas-Moreno; Manuel Muñoz-Torres
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

8.  PGC-1 mediates the regulation of metformin in muscle irisin expression and function.

Authors:  Zaigang Yang; Xu Chen; Yujuan Chen; Qian Zhao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 9.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

10.  Metabolic cross-talk between skeletal muscle and adipose tissue in high-intensity interval training vs. moderate-intensity continuous training by regulation of PGC-1α.

Authors:  Hossein Shirvani; Ehsan Arabzadeh
Journal:  Eat Weight Disord       Date:  2018-02-26       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.